MSLE Satellos Bioscience Inc. Common Stock
Healthcare$6.80+0.81%ClosedMarket Cap: $8.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.49
P/S
0.00
EV/EBITDA
-5.09
DCF Value
$7.03
FCF Yield
-23.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-51.4%
ROA
-25.6%
ROIC
-20.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-9.9M | $-9.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.6M | $-7.3M | $— | — |
| FY null | $0.00 | NaN% | $-26.5M | $-24.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.0M | $-5.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-6.4M | $-5.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.5M | $-6.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-4.6M | $-3.3M | $— | — |
| FY null | $0.00 | NaN% | $-19.4M | $-19.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.7M | $-6.6M | $— | — |
| FY null | $0.00 | NaN% | $-11.7M | $-12.0M | $— | — |
| FY null | $0.00 | NaN% | $0.00 | $-8.3M | $— | — |
| FY null | $0.00 | -Infinity% | $0.00 | $-12.2M | $— | — |